Greenwich LifeSciences (GLSI) Institutional Ownership $11.23 -0.19 (-1.66%) Closing price 04:00 PM EasternExtended Trading$11.32 +0.09 (+0.85%) As of 05:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Greenwich LifeSciences (NASDAQ:GLSI)CurrentInstitutional OwnershipPercentage4.16%Number ofInstitutional Buyers(last 12 months)16TotalInstitutional Inflows(last 12 months)$2.07MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$138.78K Get GLSI Insider Trade Alerts Want to know when executives and insiders are buying or selling Greenwich LifeSciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data GLSI Institutional Buying and Selling by Quarter Greenwich LifeSciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/13/2025 Marshall Wace LLP56,142$509K0.0%N/A0.420% 8/8/2025 Police & Firemen s Retirement System of New Jersey2,768$25K0.0%N/A0.021% 8/8/2025 Geode Capital Management LLC138,982$1.26M0.0%+1.4%1.040% 5/29/2025Rhumbline Advisers9,673$92K0.0%+48.7%0.072% 5/28/2025Strs Ohio18,600$177K0.0%N/A0.139% 5/13/2025HighTower Advisors LLC15,407$147K0.0%N/A0.116% 5/9/2025Charles Schwab Investment Management Inc.19,007$181K0.0%+15.5%0.143% 4/8/2025Rhumbline Advisers9,673$92K0.0%+48.7%0.074% 4/7/2025GAMMA Investing LLC1,202$126K0.0%N/A0.009% 2/17/2025Bank of America Corp DE7,262$82K0.0%+22.3%0.055% Get the Latest News and Ratings for GLSI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Greenwich LifeSciences and its competitors with MarketBeat's FREE daily newsletter. 2/14/2025Northern Trust Corp87,423$982K0.0%+17.3%0.665% 2/13/2025Barclays PLC9,648$108K0.0%+12.7%0.073% 2/13/2025Renaissance Technologies LLC22,700$255K0.0%-30.2%0.173% 2/13/2025Wells Fargo & Company MN2,847$32K0.0%+54.8%0.022% 2/12/2025Brown Brothers Harriman & Co.4,000$45K0.0%N/A0.030% 2/12/2025JPMorgan Chase & Co.7,061$79K0.0%+172.0%0.054% 12/10/2024Garden State Investment Advisory Services LLC17,600$253K0.1%N/A0.134% 11/19/2024Barclays PLC8,560$123K0.0%+323.3%0.065% 11/16/2024Geode Capital Management LLC133,550$1.92M0.0%+4.6%1.016% 11/15/2024Barclays PLC8,560$123K0.0%+323.3%0.065% 11/15/2024State Street Corp71,408$1.03M0.0%+4.4%0.543% 11/15/2024Garden State Investment Advisory Services LLC17,600$253K0.1%N/A0.134% 11/12/2024Charles Schwab Investment Management Inc.16,455$236K0.0%-10.8%0.125% 8/1/2024Rhumbline Advisers6,799$117K0.0%N/A0.053% 7/26/2024Bank of New York Mellon Corp15,295$264K0.0%N/A0.119% 5/10/2024Vanguard Group Inc.223,102$4.45M0.0%+0.6%1.732% 2/14/2023683 Capital Management LLC11,700$178K0.0%N/A0.091% 11/15/2022Pura Vida Investments LLC19,667$179K0.0%N/A0.153% 8/8/2022Walleye Capital LLC10,656$90K0.0%N/A0.082% 4/29/2022Nisa Investment Advisors LLC7,200$141K0.0%N/A0.056% 2/7/2022SG Americas Securities LLC4,395$107K0.0%N/A0.034% 11/15/2021Invesco Ltd.148,087$5.79M0.0%-47.1%1.138% 11/15/2021Tibra Equities Europe Ltd12,700$496K0.8%N/A0.098% 11/12/2021OLD Mission Capital LLC7,358$287K0.0%N/A0.057% 11/12/2021Geode Capital Management LLC56,919$2.22M0.0%+8.6%0.437% 8/17/2021Invesco Ltd.280,062$12.59M0.0%N/A2.171% 8/16/2021California State Teachers Retirement System5,588$251K0.0%N/A0.043% 8/16/2021Charles Schwab Investment Management Inc.9,819$442K0.0%N/A0.076% 8/16/2021State Street Corp50,212$2.26M0.0%N/A0.389% 8/16/2021Nuveen Asset Management LLC6,392$287K0.0%N/A0.050% 8/13/2021Northern Trust Corp12,098$544K0.0%N/A0.094% 8/13/2021Geode Capital Management LLC52,395$2.35M0.0%+262.3%0.406% 8/13/2021Vanguard Group Inc.121,418$5.46M0.0%+14.3%0.941% 8/12/2021State of Wisconsin Investment Board5,200$234K0.0%N/A0.040% 8/12/2021JPMorgan Chase & Co.4,789$216K0.0%N/A0.037% 8/11/2021Bank of New York Mellon Corp6,664$300K0.0%N/A0.052% 8/11/2021BlackRock Inc.217,748$9.79M0.0%+242.7%1.688% 8/11/2021Deutsche Bank AG2,396$108K0.0%N/A0.019% 8/10/2021Citigroup Inc.1,611$72K0.0%+212.8%0.012% 8/2/2021New York State Common Retirement Fund3,500$157K0.0%N/A0.027% (Data available from 1/1/2016 forward) GLSI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GLSI shares? During the previous two years, 19 institutional investors and hedge funds held shares of Greenwich LifeSciences. The most heavily invested institutionals were Vanguard Group Inc. ($4.45M), Geode Capital Management LLC ($1.26M), State Street Corp ($1.03M), Northern Trust Corp ($982K), Marshall Wace LLP ($509K), Bank of New York Mellon Corp ($264K), and Renaissance Technologies LLC ($255K).Learn more on Greenwich LifeSciences' institutional investors. What percentage of Greenwich LifeSciences' stock is owned by institutional investors? 4.16% of Greenwich LifeSciences' stock is owned by institutional investors. Learn more on GLSI's institutional investor holdings. Which institutional investors have been buying Greenwich LifeSciences' stock? Of the 18 institutional investors that purchased Greenwich LifeSciences' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Marshall Wace LLP ($56.14K), Garden State Investment Advisory Services LLC ($35.20K), Strs Ohio ($18.60K), HighTower Advisors LLC ($15.41K), Bank of New York Mellon Corp ($15.30K), Barclays PLC ($14.16K), and Rhumbline Advisers ($13.14K). How much institutional buying is happening at Greenwich LifeSciences? Institutional investors have bought a total of 186,927 shares in the last 24 months. This purchase volume represents approximately $2.07M in transactions. Which of Greenwich LifeSciences' major shareholders have been selling company stock? The following institutional investors have sold Greenwich LifeSciences stock in the last 24 months: Renaissance Technologies LLC ($9.80K), and Charles Schwab Investment Management Inc. ($2.00K). How much institutional selling is happening at Greenwich LifeSciences? Institutional investors have sold a total of 11,799 shares in the last 24 months. This volume of shares sold represents approximately $138.78K in transactions. Related Companies RZLT Institutional Ownership RLAY Institutional Ownership IMTX Institutional Ownership MRVI Institutional Ownership KROS Institutional Ownership TERN Institutional Ownership TRML Institutional Ownership SIGA Institutional Ownership PVLA Institutional Ownership IVA Institutional Ownership This page (NASDAQ:GLSI) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored6-Figure Target for BTC by 2025Trump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredWall Street laughed at Trump’s “Smart Dollar.” Now they’re all in."THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Greenwich LifeSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Greenwich LifeSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.